내용 상단 배경
 


전체 79건
제목 Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine.
저자명 Lee SJ.
저널정보 Front Genet. 2013 Feb 1;3:318. doi: 10.3389/fgene.2012.00318. eCollection 2012.
저널링크 PMID: 23378847  [link]
Keyword CYP2C19, SNP, drug, functional genetics, personalized medicine

제목 Population pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenz.
저자명 Abdelhady AM, Desta Z, Jiang F, Yeo CW, Shin JG, Overholser BR.
저널정보 J Clin Pharmacol. 2014 Jan;54(1):87-96.
저널링크 PMID: 24142869  [link]
Keyword Efavirenz, CYP2A6,2B6,3A5,MDR1

제목 The effect of CYP2C19 genotype on the time course of platelet aggregation inhibition after clopidogrel administration.
저자명 Kim HS, Cho DY, Park BM, Bae SK, Yoon YJ, Oh M, Ghim JL, Kim EY, Kim DH, Shin JG
저널정보 J Clin Pharmacol. 2013 Nov 11. doi: 10.1002/jcph.225.
저널링크 PMID: 24214141  [link]
Keyword CYP2C19, clopidogrel

제목 CYP2C19 Poor Metabolizer Is Associated with Clinical Outcome of Clopidogrel Therapy in Acute Myocardial Infarction but Not Stable Angina.
저자명 Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh MK, Kim EY, Shon JH, Shin JG, Seung KB.
저널정보 Circ Cardiovasc Genet. 2013 Oct 1;6(5):514-21
저널링크 PMID: 24019397  [link]
Keyword CYP2C19, Clopidogrel, acute myocardial infarction, angina

제목 CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-analysis of Heterogeneous Study Populations.
저자명 Province MA, Goetz MP, Brauch H, Flockhart DA, Hebert JM, Whaley R, Suman VJ, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman WG, Lee MT, Shin JG et al.
저널정보 Clin Pharmacol Ther. 2014 Feb;95(2):216-27
저널링크 PMID: 24060820  [link]
Keyword CYP2D6, Tamoxifen

   [First Page]     [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]   [다음10개]      [Last Page]


분석실 소개  |  찾아오시는 길  |  이용약관  |  개인정보 처리방침
[47397] 부산광역시 부산진구 진사로83번길 81(개금동) 인제대학교 약물유전체연구센터 | 이메일 : genotypetest@gmail.com
COPYRIGHT 2009. PHARMACOGENETIC CORE LAB . ALL RIGHTS RESERVED.

  유전형 분석 기술
  표준물질 구축
  검체 관리
  연구 실적
  
Login | Register | Sitemap | Contact Us